Thomas Nevin

753 total citations
8 papers, 546 citations indexed

About

Thomas Nevin is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Thomas Nevin has authored 8 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Thomas Nevin's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Herpesvirus Infections and Treatments (2 papers). Thomas Nevin is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Herpesvirus Infections and Treatments (2 papers). Thomas Nevin collaborates with scholars based in United States, New Zealand and Germany. Thomas Nevin's co-authors include Rebecca A. Clark, Kenneth E. Sherman, Hernan Valdez, Yijun Yang, Scott Evans, Raymond T. Chung, Cecilia M. Shikuma, Dickens Theodore, Justin C. McArthur and Christina M. Marra and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Thomas Nevin

8 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Nevin United States 7 268 199 172 128 124 8 546
Laurence Slama France 13 211 0.8× 188 0.9× 59 0.3× 176 1.4× 104 0.8× 23 462
Alexandra Scherrer Switzerland 15 380 1.4× 213 1.1× 55 0.3× 273 2.1× 86 0.7× 37 591
Rosa de Miguel Buckley Spain 15 238 0.9× 170 0.9× 134 0.8× 197 1.5× 30 0.2× 48 547
Kailapuri G. Murugavel India 16 232 0.9× 340 1.7× 41 0.2× 149 1.2× 172 1.4× 47 599
I. Grosch-Wörner Germany 9 411 1.5× 238 1.2× 105 0.6× 245 1.9× 16 0.1× 28 603
Christian Kollan Germany 13 445 1.7× 333 1.7× 44 0.3× 224 1.8× 46 0.4× 43 570
John Chuah Australia 14 479 1.8× 255 1.3× 281 1.6× 382 3.0× 22 0.2× 18 697
Renato Maserati Italy 14 263 1.0× 139 0.7× 30 0.2× 236 1.8× 77 0.6× 24 452
E Massironi Italy 13 159 0.6× 251 1.3× 41 0.2× 103 0.8× 159 1.3× 18 488
Tesfaye Tilahun Ethiopia 8 197 0.7× 138 0.7× 52 0.3× 152 1.2× 43 0.3× 12 384

Countries citing papers authored by Thomas Nevin

Since Specialization
Citations

This map shows the geographic impact of Thomas Nevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Nevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Nevin more than expected).

Fields of papers citing papers by Thomas Nevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Nevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Nevin. The network helps show where Thomas Nevin may publish in the future.

Co-authorship network of co-authors of Thomas Nevin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Nevin. A scholar is included among the top collaborators of Thomas Nevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Nevin. Thomas Nevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Frank, Ian, Ronald J. Bosch, Susan A. Fiscus, et al.. (2004). Activity, Safety, and Immunological Effects of Hydroxyurea Added to Didanosine in Antiretroviral-Naive and Experienced HIV Type 1-Infected Subjects: A Randomized, Placebo-Controlled Trial, ACTG 307. AIDS Research and Human Retroviruses. 20(9). 916–926. 21 indexed citations
2.
3.
Benson, Constance A., Paige L. Williams, David L. Cohn, et al.. (2000). Clarithromycin or Rifabutin Alone or in Combination for Primary Prophylaxis ofMycobacterium aviumComplex Disease in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases. 181(4). 1289–1297. 62 indexed citations
4.
Marra, Christina M., Justin C. McArthur, Shelley Hurwitz, et al.. (2000). A Pilot Study Evaluating Ceftriaxone and Penicillin G as Treatment Agents for Neurosyphilis in Human Immunodeficiency Virus-Infected Individuals. Clinical Infectious Diseases. 30(3). 540–544. 127 indexed citations
6.
Demeter, Lisa M., Gene D. Morse, Margaret A. Fischl, et al.. (1998). Phase I Study of Atevirdine Mesylate (U-87201E) Monotherapy in HIV-1-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(2). 135–144. 11 indexed citations
7.
Kessler, Harold A., S S Hurwitz, Charles Farthing, et al.. (1996). Pilot Study of Topical Trifluridine for the Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients with AIDS (ACTG 172). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(2). 147–152. 26 indexed citations
8.
Kessler, Harold A., Constance A. Benson, John C. Pottage, et al.. (1992). Actg 172 treatment of acyclovir resistant acv r mucocutaneous herpes simplex virus hsv infection in patients with aids open label pilot study of topical trifluridine tft. 55. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026